ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $868,000 | -7.2% | 11,606 | -21.9% | 0.61% | -10.0% |
| Q2 2020 | $935,000 | -27.4% | 14,856 | -51.6% | 0.68% | -40.6% |
| Q1 2020 | $1,288,000 | -2.6% | 30,663 | +5.4% | 1.14% | -2.6% |
| Q4 2019 | $1,322,000 | +188.6% | 29,089 | +191.0% | 1.17% | +159.2% |
| Q3 2019 | $458,000 | -17.8% | 9,997 | +5.2% | 0.45% | -11.0% |
| Q2 2019 | $557,000 | -13.0% | 9,507 | -33.4% | 0.51% | -24.6% |
| Q1 2019 | $640,000 | +8.5% | 14,267 | -5.8% | 0.67% | +7.9% |
| Q4 2018 | $590,000 | – | 15,153 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |